复宏汉霖与Dr. Reddy’s订立许可协议;阿斯利康回应涉嫌偷逃进口税款|医药早参

每日经济新闻
07 Feb

每经记者:林姿辰每经编辑:梁枭| 2025年2月7日 星期五 |NO.1 复宏汉霖与Dr. Reddy’s订立许可协议2月6日,复星医药公告,控股子公司复宏汉霖与Dr. Reddy’s签订《许可协议》,由复宏汉霖就在研产品HLX15的静脉注射制剂(IV)与皮下注射制剂(SC)剂型授予Dr. Reddy’s于许可区域[即美国及约定的欧洲地区(包括英国、瑞士等42个欧洲国家)]及许可领域(即各约定参比...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10